Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes

Diabetes Care

Volumn 34, Issue 9, 2011, Pages 2005-2007

  Kytö, Janne P ^a,b   Harjutsalo, Valma ^a,b,c   Forsblom, Carol ^a,b   Hietala, Kustaa ^a,b   Summanen, Paula A ^a   Groop, Per Henrik ^a,b,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CUMULATIVE INCIDENCE; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; ONSET AGE; TREND STUDY; ADOLESCENT; CHILD; FEMALE; MALE;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; MALE; YOUNG ADULT;

EID: 81755183621     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2391     Document Type: Article

References (13)

1. Grauslund J, Green A, Sjølie AK. Prevalence and 25 year incidence of proliferative retinopathy among Danish type 1 diabetic patients. Diabetologia 2009;52:1829-1835
2. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J; Linköping Diabetes Complications Study. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes: the Linköping Diabetes Complications Study. Diabetologia 2004;47:1266-1272 (Pubitemid 39093322)
3. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26:1258-1264 (Pubitemid 36929282)
4. Thorn LM, Forsblom C, Fagerudd J, et al.; FinnDiane Study Group. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005;28:2019-2024 (Pubitemid 41060978)
5. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008;115:1859-1868
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
7. Sane T, Tulokas T, Nikkanen P, Heikkilä P, Huttunen E, Niskanen L. Insulin pump in the treatment of adult age diabetes. Duodecim 2005;121:839-845 [in Finnish]
8. Caird FI, Burditt AF, Draper GJ. Diabetic retinopathy: a further study of prognosis for vision. Diabetes 1968;17:121-123
9. Deckert T, Simonsen SE, Poulsen JE. Prognosis of proliferative retinopathy in juvenile diabetics. Diabetes 1967;16:728-733
10. Suomen Diabetesliitto ry:n retinopatiatyöryhmä(The Finnish Diabetes Association Retinopathy Work Group). Diabeettinen retinopatia: Seuranta, hoito ja näkövammautuneen diabeetikon kuntoutus. Suom Laakaril 1992;47:2199-2211 [in Finnish]
11. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetesmellitus.N Engl J Med 1994;330:15-18 (Pubitemid 24018611)
12. Hietala K, Harjutsalo V, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care 2010;33:1315-1319
13. Grassi MA, Mazzulla DA, Knudtson MD, et al. Patient self-report of prior laser treatment reliably indicates presence of severe diabetic retinopathy. Am J Ophthalmol 2009;147:501-504